Cellumed Co Ltd - ESG Rating & Company Profile powered by AI
Full ESG assessment of Cellumed Co Ltd can be reached by logging in. This analysis of Cellumed Co Ltd employs data from across the web and also from available documents by Cellumed Co Ltd. The webpage of Cellumed Co Ltd was assembled by All Street Sevva using leading artificial intelligence.
Cellumed Co Ltd in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Analytik Jena AG | 8.0 | High |
| 1 | Amniotics AB (publ) | 8.0 | High |
| ... | ... | ... | |
| 179 | Exagen Inc | 0.7 | Low |
| 179 | Mertiva AB | 0.7 | Low |
| 182 | Cellumed Co Ltd | 0.0 | Low |
| 182 | Cadus Corp | 0.0 | Low |
| 182 | Cambridge Chocolate Technologies SA | 0.0 | Low |
| 182 | Wesana Health Holdings Inc | 0.0 | Low |
| 182 | rEVO Biologics Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cellumed Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cellumed Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Cellumed Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Cellumed Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cellumed Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cellumed Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Cellumed Co Ltd offer flexible work?
Sign up for free to unlockDoes Cellumed Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cellumed Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cellumed Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Cellumed Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cellumed Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cellumed Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cellumed Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cellumed Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cellumed Co Ltd disclose water use targets?
Sign up for free to unlockDoes Cellumed Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Cellumed Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Cellumed Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Cellumed Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cellumed Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cellumed Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Cellumed Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cellumed Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cellumed Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cellumed Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cellumed Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cellumed Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cellumed Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Cellumed Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cellumed Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Cellumed Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Cellumed Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cellumed Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Cellumed Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cellumed Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cellumed Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Cellumed Co., Ltd., a medical device biotechnology company, provides bone graft materials, implants, growth factors, and healthcare in Korea. It offers allograft products, which include achilles tendon, patellar tendon, and tibialis tendon that are used to reconstruct anterior and posterior cruciate ligaments; bone powder/chip that comprise DBM powder, cancellous bone coarse, and cancellous bone cube for the purpose of filling bone defects; and meniscus, a material used to reconstruct the meniscus between the knee joints in case of damage due to accidents, etc. The company also provides biologics comprising Rafugen DBM Gel Pro used for bone regeneration; bio meniscus graft, a supplement for meniscal cartilage; Bio BMP2, a bone graft material containing bone formation-inducing protein; Intergraft, a bone graft material for bone regeneration; and viscoseal syringe that temporarily replaces lost synovial fluid and helps in restoration of joint function. Additionally, the company offers joint replacement products comprising luminus flex total knee system and suminus flex patient-specific Instrument system, as well as engaged in cosmeceutical business. The company was formerly known as Korea Bone Bank Co., Ltd. and changed its name to Cellumed Co., Ltd. The company was founded in 1997 and is based in Seoul, South Korea.